Intersect ENT, Inc. (NASDAQ:XENT) Q3 2018 Earnings Conference Call Transcript

Nov 05, 2018 • 08:00 am ET


Intersect ENT, Inc. (NASDAQ:XENT) Q3 2018 Earnings Conference Call Transcript


Loading Event

Loading Transcript


Good morning and welcome to the Intersect ENT Third Quarter 2018 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded. I now would like to turn the conference over to Jeri Hilleman, Chief Financial Officer. Please go ahead.

Jeryl Hilleman

Thank you, Keith, and thank you all for participating on today's call. Joining me today is Lisa Earnhardt, President and CEO. Before we begin, I'd like to remind you that we will make forward-looking statements within the meaning of federal securities laws. Actual results and timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, our outlook for financial performance, sales force growth, clinical studies, approval of new products and indications and procurement of reimbursement codes and coverage, which are based upon our current estimates and assumptions as well as other risks detailed from time to time in the reports we file with the SEC. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein.I'll now turn the call over to Lisa Earnhardt. Lisa?